Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02661503
Title HD21 for Advanced Stages
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Cologne
Indications

Hodgkin's lymphoma

Therapies

Brentuximab vedotin + Cyclophosphamide + Dacarbazine + Dexamethasone + Doxorubicin + Etoposide

Bleomycin + Cyclophosphamide + Doxorubicin + Etoposide + Prednisone + Procarbazine + Vincristine Sulfate

Age Groups:
Covered Countries DEU


No variant requirements are available.